As Congress and the Trump Administration consider policies to address rising prescription drug prices, the National Coalition on Health Care (NCHC) hosted a Capitol Hill briefing on March 15th to put one promising option on the table: the use of binding arbitration in Medicare Part D to determine prices for a limited set of drugs. […]
Surprise Medical Billing Legislation: Issues for Congress to Consider
FACT SHEET Legislative solutions are needed to combat the rising cost of health care in the United States, which accounted for almost 18% of the GDP in 2017. One symptom of the problem, surprise medical bills, contributes to unpredictable, high out-of-pocket costs for consumers. Patients often encounter surprise medical bills when receiving emergency or ancillary […]
John Rother’s Orphan Drug Presentation
On April 10th, NCHC President & CEO John Rother presented at the World Orphan Drug Congress 2019 Conference & Expo to discuss potential policy options to address the rising cost of drugs. Mr. Rother discussed proposals from the FDA, HHS, and Congress. Mr. Rother also identified 4 feasible options to address drug affordability. The slides […]
NCHC Writes Letter to Senator Alexander on Health Care Costs
On February 28th, NCHC wrote a letter to the Senate HELP Committee addressed to Senator Alexander. The letter was in response to a request from Senator Alexander asking for policy recommendations to address the rising costs of health care. You can read the entire letter here.
NCHC comments on Medicare Advantage Telehealth Benefits
On December 31st, 2018, the National Coalition on Health Care commented on CMS’ requirements for Medicare Advantage plans that offer additional telehealth benefits. NCHC noted that the “current limitations on the use of telehealth services are antiquated,” pointing to the fact that it was estimated that only 0.25 percent of Medicare beneficiaries were able to […]
- 1
- 2
- 3
- …
- 29
- Next Page »